Drug intelligence / Profile preview

mRNA-1018

Development stage: Phase 3
Lead developer: Moderna
Modality: mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

mRNA-1018 is an investigational mRNA-based vaccine developed for the prevention of pandemic influenza, specifically targeting H5 and H7 avian influenza virus subtypes. The vaccine uses messenger RNA (mRNA) technology to instruct cells to produce viral antigens, thereby eliciting an immune response against the targeted influenza strains. It is administered via intramuscular injection and is currently in Phase 2 clinical development. Moderna, a biotechnology company specializing in mRNA therapeutics and vaccines, is both the developer and manufacturer of this candidate[2][3][4][5][8].

Other names: Pandemic flu vaccinePandemic influenza vaccineModerna pandemic flu vaccine

Targets

Translation factors (Translation initiation/elongation factors)

Beyond the preview

Go deeper on mRNA-1018.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mRNA-1018.

Explore the full profile